IT1205042B - Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer - Google Patents

Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer

Info

Publication number
IT1205042B
IT1205042B IT20698/87A IT2069887A IT1205042B IT 1205042 B IT1205042 B IT 1205042B IT 20698/87 A IT20698/87 A IT 20698/87A IT 2069887 A IT2069887 A IT 2069887A IT 1205042 B IT1205042 B IT 1205042B
Authority
IT
Italy
Prior art keywords
alzheimer
desence
senile
type
treatment
Prior art date
Application number
IT20698/87A
Other languages
English (en)
Other versions
IT8720698A0 (it
Inventor
Umberto Cornelli
Thomas A Ban
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Priority to IT20698/87A priority Critical patent/IT1205042B/it
Publication of IT8720698A0 publication Critical patent/IT8720698A0/it
Priority to US07/197,419 priority patent/US4956347A/en
Priority to ES198888201047T priority patent/ES2040323T3/es
Priority to DE8888201047T priority patent/DE3865099D1/de
Priority to AT88201047T priority patent/ATE67666T1/de
Priority to EP88201047A priority patent/EP0293974B1/en
Priority to JP63128581A priority patent/JPS6419021A/ja
Application granted granted Critical
Publication of IT1205042B publication Critical patent/IT1205042B/it
Priority to GR91401381T priority patent/GR3002802T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IT20698/87A 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer IT1205042B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT20698/87A IT1205042B (it) 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer
US07/197,419 US4956347A (en) 1987-05-28 1988-05-23 Use of sulfomucopolysaccharides in the treatment of Alzheimer-type senile dementia
ES198888201047T ES2040323T3 (es) 1987-05-28 1988-05-24 Procedimiento de preparacion de composiciones para el tratamiento terapeutico de la demencia senil tipo alzheimer.
DE8888201047T DE3865099D1 (de) 1987-05-28 1988-05-24 Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.
AT88201047T ATE67666T1 (de) 1987-05-28 1988-05-24 Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.
EP88201047A EP0293974B1 (en) 1987-05-28 1988-05-24 Use of sulfomucopolysaccharides in the therapeutical treatment of alzheimer-type senile dementia
JP63128581A JPS6419021A (en) 1987-05-28 1988-05-27 Use of sulfomco polysaccharides for therapeutically treating alzheimer's senile dementia
GR91401381T GR3002802T3 (en) 1987-05-28 1991-09-26 Use of sulfomucopolysaccharides in the therapeutical treatment of alzheimer-type senile dementia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20698/87A IT1205042B (it) 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer

Publications (2)

Publication Number Publication Date
IT8720698A0 IT8720698A0 (it) 1987-05-28
IT1205042B true IT1205042B (it) 1989-03-10

Family

ID=11170725

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20698/87A IT1205042B (it) 1987-05-28 1987-05-28 Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer

Country Status (8)

Country Link
US (1) US4956347A (it)
EP (1) EP0293974B1 (it)
JP (1) JPS6419021A (it)
AT (1) ATE67666T1 (it)
DE (1) DE3865099D1 (it)
ES (1) ES2040323T3 (it)
GR (1) GR3002802T3 (it)
IT (1) IT1205042B (it)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699968B1 (en) 1989-03-29 2004-03-02 Children's Medical Center Corporation Construction and use of synthetic constructs encoding syndecan
US5486599A (en) * 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
ES2059602T3 (es) * 1989-04-14 1994-11-16 Merz & Co Gmbh & Co Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral.
FR2655267B1 (fr) * 1989-12-04 1992-04-03 Roussel Uclaf Nouveau derive sulfate du galactanne extrait de klebsiella, procede de preparation, application a titre de medicaments et compositions pharmaceutiques le renfermant.
IT1240615B (it) * 1990-04-03 1993-12-17 Mediolanum Farmaceutici Spa Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale
US5164295A (en) * 1991-03-06 1992-11-17 The Upjohn Company Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds
US5958883A (en) 1992-09-23 1999-09-28 Board Of Regents Of The University Of Washington Office Of Technology Animal models of human amyloidoses
US20040208875A1 (en) * 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
WO1994022437A2 (en) * 1993-03-29 1994-10-13 Queen's University At Kingston Method for treating amyloidosis
US5505948A (en) * 1993-06-01 1996-04-09 Dermatology Home Products, Inc. Home skin peel composition for producing healthy and attractive skin
US6245751B1 (en) 1996-07-09 2001-06-12 University Of Cincinnati Methods for the treatment of apolipoprotein E related diseases
US6277874B1 (en) * 1996-07-09 2001-08-21 University Of Cincinnati And Apologic, Incorporated Methods for the treatment of apolipoprotein E related diseases
EP1014996B1 (en) * 1997-08-28 2003-05-28 University of Washington Saccharide-containing compositions for treating alzheimer's disease and other amyloidoses
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
NZ543319A (en) * 1999-04-28 2007-06-29 Neurochem Int Ltd Compositions and methods for treating amyloidosis using sulphonate derivatives
IT1312107B1 (it) * 1999-05-14 2002-04-04 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile
US6608042B2 (en) * 2000-03-28 2003-08-19 Aventis Pharma, S.A. Pharmaceutical compositions containing oligosaccharides, the novel oligosaccharides and preparation thereof
ITMI20031023A1 (it) * 2003-05-21 2004-11-22 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20060074049A1 (en) * 2004-10-05 2006-04-06 Mitchell Krathwohl Use of heparinoids for treatment and prevention of dementia
BRPI0517790A (pt) * 2004-11-12 2008-10-21 Neurochem Int Ltd métodos e composições fluoradas para tratar doenças relacionadas à amilóide
CA2586334A1 (en) * 2004-11-16 2006-06-08 Neurochem (International) Limited Compounds for the treatment of cns and amyloid associated diseases
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
WO2006111348A1 (de) * 2005-04-18 2006-10-26 Abbott Gmbh & Co. Kg Verwendung von heparin und heparinderivaten zur modulation des neuritenwachstum-kontrollierenden nogo-rezeptors
MX2008008213A (es) * 2005-12-22 2008-09-03 Neurochem Int Ltd Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias.
KR101608445B1 (ko) 2006-10-12 2016-04-01 비에이치아이 리미티드 파트너쉽 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
EP2120905A1 (en) * 2006-12-22 2009-11-25 BELLUS Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
WO2015184231A2 (en) * 2014-05-30 2015-12-03 Kolltan Pharmaceuticals, Inc. Regulators of anaplastic lymphoma kinase and uses thereof
JP2023159833A (ja) * 2022-04-20 2023-11-01 江南化工株式会社 脳機能改善用組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3000787A (en) * 1957-11-06 1961-09-19 Crinos Industria Farmaco Heparinoid anticholestrolemic factor
US3007787A (en) * 1960-03-16 1961-11-07 Monsanto Chemicals Butyl xylyl sulfone

Also Published As

Publication number Publication date
US4956347A (en) 1990-09-11
DE3865099D1 (de) 1991-10-31
EP0293974B1 (en) 1991-09-25
EP0293974A1 (en) 1988-12-07
ATE67666T1 (de) 1991-10-15
JPS6419021A (en) 1989-01-23
ES2040323T3 (es) 1993-10-16
IT8720698A0 (it) 1987-05-28
GR3002802T3 (en) 1993-01-25

Similar Documents

Publication Publication Date Title
GR3002802T3 (en) Use of sulfomucopolysaccharides in the therapeutical treatment of alzheimer-type senile dementia
ATE308336T1 (de) Osteogenische proteine in der behandlung von metabolischen knochenkrankheiten
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
MX9203543A (es) Medicamento.
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
JPS6485984A (en) Methylenephosphonoalkylphosphinates, medicinal composition and therapy for abnormal calcium and phosphate metabolism
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
ATE82294T1 (de) Therapeutische nukleoside.
DK197286A (da) Terapeutiske praeparater til detektering og/eller behandling af pattedyrtumorer
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
FI92320C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
DE3685275D1 (de) Herstellung von 5-fluor-2'-deoxyuridin estern zur intravenoesen verabreichung.
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
EP0295559A3 (en) Pharmaceutical composition for the treatment of tumors
IT1223395B (it) Composti ad attivita' cardiovascolare
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.
NO180085C (no) Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreestere og deres anvendelse som legemidler
FI863079A0 (fi) Kontinuerligt frigoerande fenyletanolaminderivatkompositioner.
IL87867A (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-3-phenyl-azo-pyridine derivative
IT8619086A0 (it) Composizioni farmaceutiche comprendenti frammenti di acth per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria.
DK681288A (da) Aenootropt terapeutisk laegemiddelae
IT212642Z2 (it) Perfezionamento del controllore dell'iniezione di gocce medicinali
DK159118C (da) 6alfa-methylprednisolon-derivater og farmaceutiske praeparater der indeholder dem

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960509